The Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA; Allergan) for the treatment of upper limb spasticity in pediatric patients 2-17 years of age. The approval was based on ...
The US Food and Drug Administration (FDA) has approved onabotulinumtoxinA (Botox, Allergan) to ease upper limb spasticity in children and adolescents aged 2 to 17 years, the company announced. Common ...
Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...
Henry Winkler, known for his television role as Arthur "The Fonz" Fonzarelli, made it a happy day for many people in the Triangle Tuesday who suffer from upper limb spasticity. Henry Winkler, known ...
FDA approved an expanded Botox label, which now includes eight new muscles to treat adults with upper limb spasticity. On July 29, 2021, Allergan, an AbbVie company, announced that FDA approved a ...
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Allergan plc AGN announced that the FDA has approved its supplemental biologics license application (sBLA) to expand the label of its blockbuster product Botox for pediatric patients with upper limb ...
Please provide your email address to receive an email when new articles are posted on . Allergan announced that the FDA has approved its supplemental biologics application for Botox, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback